0001104659-24-029655.txt : 20240301 0001104659-24-029655.hdr.sgml : 20240301 20240301083010 ACCESSION NUMBER: 0001104659-24-029655 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240301 DATE AS OF CHANGE: 20240301 EFFECTIVENESS DATE: 20240301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Icosavax, Inc. CENTRAL INDEX KEY: 0001786255 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 001-40655 FILM NUMBER: 24707074 BUSINESS ADDRESS: STREET 1: 1930 BOREN AVE., SUITE 1000 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: (206) 737-0085 MAIL ADDRESS: STREET 1: 1930 BOREN AVE., SUITE 1000 CITY: SEATTLE STATE: WA ZIP: 98101 15-12G 1 tm247556d1_1512g.htm FORM 15-12G

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 15

 

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 001-40655

 

 

 

Icosavax, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

1930 Boren Avenue, Suite 1000

Seattle, Washington 98101

(206) 737-0085

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, par value $0.0001 per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

  Rule 12g-4(a)(1) x
  Rule 12g-4(a)(2) ¨
  Rule 12h-3(b)(1)(i) x
  Rule 12h-3(b)(1)(ii) ¨
  Rule 15d-6 ¨
  Rule 15d-22(b) ¨

 

Approximate number of holders of record as of the certification or notice date: One.

 

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Icosavax, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

 

Icosavax, Inc.

     
Date: March 1, 2024 By: /s/ David E. White
   

David E. White

Vice President

 

2